Cellectis SA (CLLS)
2.506
+0.02
(+0.63%)
USD |
NASDAQ |
Apr 26, 16:00
2.50
-0.01
(-0.22%)
After-Hours: 20:00
Cellectis Debt to Equity Ratio: 0.4195 for Sept. 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.4195 |
| June 30, 2023 | 0.3464 |
| March 31, 2023 | 0.1552 |
| December 31, 2022 | 0.1572 |
| September 30, 2022 | 0.1835 |
| June 30, 2022 | 0.1141 |
| March 31, 2022 | 0.1078 |
| December 31, 2021 | 0.095 |
| September 30, 2021 | 0.0903 |
| June 30, 2021 | 0.0802 |
| March 31, 2021 | 0.089 |
| December 31, 2020 | 0.0853 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.1393 |
| June 30, 2019 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.0005 |
| June 30, 2018 | 0.0017 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.0001 |
| March 31, 2017 | 0.0014 |
| December 31, 2016 | 0.0062 |
| September 30, 2016 | 0.0074 |
| June 30, 2016 | 0.0083 |
| March 31, 2016 | 0.0075 |
| December 31, 2015 | 0.007 |
| September 30, 2015 | 0.0128 |
| June 30, 2015 | 0.0118 |
| March 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.4195
Maximum
Sep 2023
0.1146
Average
0.0927
Median
Debt to Equity Ratio Benchmarks
| DBV Technologies SA | -- |
| Genfit SA | 0.9462 |
| Biophytis SA | -- |
| Edap TMS SA | 0.1057 |
| Biodexa Pharmaceuticals Plc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 209.70M |
| Total Liabilities (Quarterly) | 133.58M |
| Shareholders Equity (Quarterly) | 76.12M |
| Current Ratio | 2.195 |
| Net Debt Paydown Yield | -2.88% |